These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12164794)

  • 1. Leukocytapheresis using a leukocyte removal filter.
    Shirokaze J
    Ther Apher; 2002 Aug; 6(4):261-6. PubMed ID: 12164794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellsorba.
    Shibata H; Kuriyama T; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):44-7. PubMed ID: 12921114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current topics on cytapheresis technologies.
    Yamaji K; Tsuda H; Hashimoto H
    Ther Apher; 2001 Aug; 5(4):287-92. PubMed ID: 11724514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease.
    Kawamura A; Saitoh M; Yonekawa M; Horie T; Ohizumi H; Tamaki T; Kukita K; Meguro J
    Ther Apher; 1999 Nov; 3(4):334-7. PubMed ID: 10608731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease.
    Mitsuyama K; Yamasaki H; Kuwaki K; Takedatsu H; Sata M
    Curr Pharm Des; 2009; 15(18):2110-9. PubMed ID: 19519448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytapheresis.
    Takenaka Y
    Artif Organs; 1996 Aug; 20(8):914-6. PubMed ID: 8853806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis.
    Sawada K; Ohnishi K; Kosaka T; Chikano S; Yokota Y; Egashira A; Izawa H; Yamamura M; Amano K; Satomi M; Shimoyama T
    Ther Apher; 1997 Aug; 1(3):207-11. PubMed ID: 10225739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytapheresis therapy by extracorporeal circulation using a leukocyte removal filter.
    Suemitsu J; Yoshida M; Yamawaki N; Yamashita Y
    Ther Apher; 1998 Feb; 2(1):31-6. PubMed ID: 10227786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis.
    Kanke K; Hoshino M; Tominaga K; Nakano M; Terano A; Hiraishi H
    Blood Purif; 2007; 25(4):370-6. PubMed ID: 17785966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis.
    Eguchi K; Saito K; Kondo M; Hidaka T; Ueki Y; Tanaka Y;
    Mod Rheumatol; 2007; 17(6):481-5. PubMed ID: 18084700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytapheresis in rheumatoid arthritis.
    Hidaka T; Hashiba Y; Kubo K; Kai Y; Maeda K
    Transfus Apher Sci; 2017 Oct; 56(5):698-702. PubMed ID: 28918917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic cytapheresis for inflammatory bowel disease.
    Sawada K; Shimoyama T
    Ther Apher; 1998 May; 2(2):90-2. PubMed ID: 10225705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of immature neutrophils in peripheral blood following leukocytapheresis therapy for rheumatoid arthritis.
    Okawa-Takatsuji M; Nagatani K; Nakajima K; Itoh K; Kano T; Nagashio C; Takahashi Y; Aotsuka S; Mimori A
    J Clin Apher; 2007; 22(6):323-9. PubMed ID: 18095302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.
    Sawada K; Ohnishi K; Fukui S; Yamada K; Yamamura M; Amano K; Amano K; Wada M; Tanida N; Satomi M
    J Gastroenterol; 1995 Jun; 30(3):322-9. PubMed ID: 7647899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of filtration leukocytapheresis(LCAP) in rheumatoid arthritis(RA)].
    Ueki Y; Takashima H; Matsumoto K; Miyake S; Hidaka T; Suzuki K; Eguchi K
    Nihon Rinsho; 2002 Dec; 60(12):2296-303. PubMed ID: 12510353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K
    World J Gastroenterol; 2005 May; 11(20):3085-90. PubMed ID: 15918195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic clinical study of an easy and effective leukocytapheresis by the use of nonwoven polyester filter.
    Kawamura A; Osanai M; Katori M; Yonekawa M; Saitoh M
    Ther Apher; 1998 Nov; 2(4):292-6. PubMed ID: 10227758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis.
    Onuma S; Yamaji K; Kempe K; Ogasawara M; Ogawa T; Yang K; Kanai M; Tsuda H; Takasaki Y
    Ther Apher Dial; 2006 Oct; 10(5):404-11. PubMed ID: 17096694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis.
    Hidaka T; Suzuki K
    Ther Apher; 1997 Aug; 1(3):212-4. PubMed ID: 10225740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.